134 related articles for article (PubMed ID: 27573572)
1. Depletion of SENP1 suppresses the proliferation and invasion of triple-negative breast cancer cells.
Wang Z; Jin J; Zhang J; Wang L; Cao J
Oncol Rep; 2016 Oct; 36(4):2071-8. PubMed ID: 27573572
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract][Full Text] [Related]
3. Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression.
Kim S; Han J; Jeon M; You D; Lee J; Kim HJ; Bae S; Nam SJ; Lee JE
Tumour Biol; 2016 Aug; 37(8):11397-407. PubMed ID: 26984157
[TBL] [Abstract][Full Text] [Related]
4. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
5. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
[TBL] [Abstract][Full Text] [Related]
6. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
Song X; Zhou X; Qin Y; Yang J; Wang Y; Sun Z; Yu K; Zhang S; Liu S
Int J Mol Med; 2018 Jul; 42(1):579-588. PubMed ID: 29693154
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CDCA7 predicts poor prognosis and induces EZH2-mediated progression of triple-negative breast cancer.
Ye L; Li F; Song Y; Yu D; Xiong Z; Li Y; Shi T; Yuan Z; Lin C; Wu X; Ren L; Li X; Song L
Int J Cancer; 2018 Nov; 143(10):2602-2613. PubMed ID: 30151890
[TBL] [Abstract][Full Text] [Related]
8. E1A-mediated inhibition of HSPA5 suppresses cell migration and invasion in triple-negative breast cancer.
Chen HA; Chang YW; Tseng CF; Chiu CF; Hong CC; Wang W; Wang MY; Hsiao M; Ma JT; Chen CH; Jiang SS; Wu CH; Hung MC; Huang MT; Su JL
Ann Surg Oncol; 2015 Mar; 22(3):889-98. PubMed ID: 25212833
[TBL] [Abstract][Full Text] [Related]
9. NOTCH4 is a potential therapeutic target for triple-negative breast cancer.
Nagamatsu I; Onishi H; Matsushita S; Kubo M; Kai M; Imaizumi A; Nakano K; Hattori M; Oda Y; Tanaka M; Katano M
Anticancer Res; 2014 Jan; 34(1):69-80. PubMed ID: 24403446
[TBL] [Abstract][Full Text] [Related]
10. SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation.
Gao Y; Wang R; Liu J; Zhao K; Qian X; He X; Liu H
Int J Biol Sci; 2022; 18(5):2186-2201. PubMed ID: 35342335
[TBL] [Abstract][Full Text] [Related]
11. ARHGAP18 Downregulation by miR-200b Suppresses Metastasis of Triple-Negative Breast Cancer by Enhancing Activation of RhoA.
Humphries B; Wang Z; Li Y; Jhan JR; Jiang Y; Yang C
Cancer Res; 2017 Aug; 77(15):4051-4064. PubMed ID: 28619708
[TBL] [Abstract][Full Text] [Related]
12. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
13. PIBF1 suppresses the ATR/CHK1 signaling pathway and promotes proliferation and motility of triple-negative breast cancer cells.
Ro EJ; Ryu SH; Park EY; Ryu JW; Byun SJ; Heo SH; Kim KH; Baek IJ; Son BH; Lee SW
Breast Cancer Res Treat; 2020 Aug; 182(3):591-600. PubMed ID: 32529408
[TBL] [Abstract][Full Text] [Related]
14. miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer.
Yan M; Li X; Tong D; Han C; Zhao R; He Y; Jin X
Oncol Rep; 2016 Jul; 36(1):65-71. PubMed ID: 27108696
[TBL] [Abstract][Full Text] [Related]
15. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
16. miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.
Zhou W; Song F; Wu Q; Liu R; Wang L; Liu C; Peng Y; Mao S; Feng J; Chen C
PLoS One; 2017; 12(4):e0176395. PubMed ID: 28437471
[TBL] [Abstract][Full Text] [Related]
17. FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer.
Wu J; Liu P; Tang H; Shuang Z; Qiu Q; Zhang L; Song C; Liu L; Xie X; Xiao X
Curr Cancer Drug Targets; 2018; 18(4):382-389. PubMed ID: 29484998
[TBL] [Abstract][Full Text] [Related]
18. Up-regulated circBACH2 contributes to cell proliferation, invasion, and migration of triple-negative breast cancer.
Wang X; Xue B; Zhang Y; Guo G; Duan X; Dou D
Cell Death Dis; 2021 Apr; 12(5):412. PubMed ID: 33875646
[TBL] [Abstract][Full Text] [Related]
19. Unique cartilage matrix-associated protein inhibits the migratory and invasive potential of triple-negative breast cancer.
Lee SH; Lee YJ; Park SI; Kim JE
Biochem Biophys Res Commun; 2020 Oct; 530(4):680-685. PubMed ID: 32768190
[TBL] [Abstract][Full Text] [Related]
20. FGF13 promotes metastasis of triple-negative breast cancer.
Johnstone CN; Pattison AD; Harrison PF; Powell DR; Lock P; Ernst M; Anderson RL; Beilharz TH
Int J Cancer; 2020 Jul; 147(1):230-243. PubMed ID: 31957002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
